Year |
Citation |
Score |
2024 |
Julg B, Walker-Sperling VEK, Wagh K, Aid M, Stephenson KE, Zash R, Liu J, Nkolola JP, Hoyt A, Castro M, Serebryannyy L, Yanosick K, Speidel T, Borducchi EN, Murzda T, ... ... Giorgi EE, et al. Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1/2a trial. Nature Medicine. PMID 39266747 DOI: 10.1038/s41591-024-03247-5 |
0.417 |
|
2024 |
Kenny A, van Duijn J, Dintwe O, Heptinstall J, Burnham R, Sawant S, Zhang L, Mielke D, Khuzwayo S, Omar FL, Stanfield-Oakley S, Keyes T, Dunn B, Goodman D, Fong Y, ... ... Giorgi EE, et al. Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study. Ebiomedicine. 108: 105320. PMID 39236556 DOI: 10.1016/j.ebiom.2024.105320 |
0.351 |
|
2024 |
Giorgi EE, Li H, Hora B, Shaw GM, Wagh K, Williams WB. Viral Envelope Evolution in Simian-HIV-Infected Neonate and Adult-Dam Pairs of Rhesus Macaques. Viruses. 16. PMID 39066177 DOI: 10.3390/v16071014 |
0.468 |
|
2024 |
Juraska M, Bai H, deCamp AC, Magaret CA, Li L, Gillespie K, Carpp LN, Giorgi EE, Ludwig J, Molitor C, Hudson A, Williamson BD, Espy N, Simpkins B, Rudnicki E, et al. Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features. Proceedings of the National Academy of Sciences of the United States of America. 121: e2308942121. PMID 38241441 DOI: 10.1073/pnas.2308942121 |
0.399 |
|
2023 |
Wan M, Yang X, Sun J, Giorgi EE, Ding X, Zhou Y, Zhang Y, Su W, Jiang C, Shan Y, Gao F. Enhancement of Neutralization Responses through Sequential Immunization of Stable Env Trimers Based on Consensus Sequences from Select Time Points by Mimicking Natural Infection. International Journal of Molecular Sciences. 24. PMID 37628824 DOI: 10.3390/ijms241612642 |
0.411 |
|
2023 |
Mkhize NN, Yssel A, Kaldine H, van Dorsten RT, Woodward Davis AS, Beaume N, Matten D, Lambson B, Modise T, Kgagudi P, York T, Westfall DH, Giorgi EE, Korber B, Anthony C, et al. Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials. Plos Pathogens. 19: e1011469. PMID 37384759 DOI: 10.1371/journal.ppat.1011469 |
0.404 |
|
2023 |
Seaton KE, Huang Y, Karuna S, Heptinstall JR, Brackett C, Chiong K, Zhang L, Yates NL, Sampson M, Rudnicki E, Juraska M, deCamp AC, Edlefsen PT, Mullins JI, Williamson C, ... ... Giorgi EE, et al. Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition. Ebiomedicine. 93: 104590. PMID 37300931 DOI: 10.1016/j.ebiom.2023.104590 |
0.339 |
|
2023 |
Cohen KW, Fiore-Gartland A, Walsh SR, Yusim K, Frahm N, Elizaga ML, Maenza J, Scott H, Mayer KH, Goepfert PA, Edupuganti S, Pantaleo G, Hutter J, Morris DE, De Rosa SC, ... ... Giorgi EE, et al. Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults. The Journal of Clinical Investigation. 133. PMID 36787249 DOI: 10.1172/JCI163338 |
0.37 |
|
2023 |
Bibollet-Ruche F, Russell RM, Ding W, Liu W, Li Y, Wagh K, Wrapp D, Habib R, Skelly AN, Roark RS, Sherrill-Mix S, Wang S, Rando J, Lindemuth E, Cruickshank K, ... ... Giorgi EE, et al. A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing Antibodies. Mbio. e0337022. PMID 36629414 DOI: 10.1128/mbio.03370-22 |
0.346 |
|
2022 |
Gilbert PB, Huang Y, deCamp AC, Karuna S, Zhang Y, Magaret CA, Giorgi EE, Korber B, Edlefsen PT, Rossenkhan R, Juraska M, Rudnicki E, Kochar N, Huang Y, Carpp LN, et al. Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition. Nature Medicine. PMID 35995954 DOI: 10.1038/s41591-022-01953-6 |
0.411 |
|
2022 |
Julg B, Stephenson KE, Wagh K, Tan SC, Zash R, Walsh S, Ansel J, Kanjilal D, Nkolola J, Walker-Sperling VEK, Ophel J, Yanosick K, Borducchi EN, Maxfield L, Abbink P, ... ... Giorgi EE, et al. Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial. Nature Medicine. PMID 35551291 DOI: 10.1038/s41591-022-01815-1 |
0.365 |
|
2022 |
Tu JJ, Kumar A, Giorgi EE, Eudailey J, LaBranche CC, Martinez DR, Fouda GG, Moreau Y, Thomas A, Montefiori D, Gao F, Sagar M, Permar SR. Vertical HIV-1 Transmission in the Setting of Maternal Broad and Potent Antibody Responses. Journal of Virology. e0023122. PMID 35536018 DOI: 10.1128/jvi.00231-22 |
0.418 |
|
2021 |
Stephenson KE, Julg B, Tan CS, Zash R, Walsh SR, Rolle CP, Monczor AN, Lupo S, Gelderblom HC, Ansel JL, Kanjilal DG, Maxfield LF, Nkolola J, Borducchi EN, Abbink P, ... ... Giorgi EE, et al. Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial. Nature Medicine. PMID 34621054 DOI: 10.1038/s41591-021-01509-0 |
0.444 |
|
2021 |
Marichannegowda MH, Mengual M, Kumar A, Giorgi EE, Tu JJ, Martinez DR, Romero-Severson EO, Li X, Feng L, Permar SR, Gao F. Different evolutionary pathways of HIV-1 between fetus and mother perinatal transmission pairs indicate unique immune selection in fetuses. Cell Reports. Medicine. 2: 100315. PMID 34337555 DOI: 10.1016/j.xcrm.2021.100315 |
0.45 |
|
2021 |
Fischer W, Giorgi EE, Chakraborty S, Nguyen K, Bhattacharya T, Theiler J, Goloboff PA, Yoon H, Abfalterer W, Foley BT, Tegally H, San JE, de Oliveira T, Gnanakaran S, et al. HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens. Cell Host & Microbe. PMID 34242582 DOI: 10.1016/j.chom.2021.05.012 |
0.396 |
|
2021 |
Wee EG, Moyo N, Hannoun Z, Giorgi EE, Korber B, Hanke T. Effect of epitope variant co-delivery on the depth of CD8 T cell responses induced by HIV-1 conserved mosaic vaccines. Molecular Therapy. Methods & Clinical Development. 21: 741-753. PMID 34169114 DOI: 10.1016/j.omtm.2021.04.018 |
0.389 |
|
2021 |
Kumar A, Giorgi EE, Tu JJ, Martinez DR, Eudailey J, Mengual M, Honnayakanahalli Marichannegowda M, Van Dyke R, Gao F, Permar SR. Mutations that confer resistance to broadly-neutralizing antibodies define HIV-1 variants of transmitting mothers from that of non-transmitting mothers. Plos Pathogens. 17: e1009478. PMID 33798244 DOI: 10.1371/journal.ppat.1009478 |
0.355 |
|
2020 |
Roark RS, Li H, Williams WB, Chug H, Mason RD, Gorman J, Wang S, Lee FH, Rando J, Bonsignori M, Hwang KK, Saunders KO, Wiehe K, Moody MA, Hraber PT, ... ... Giorgi EE, et al. Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth. Science (New York, N.Y.). PMID 33214287 DOI: 10.1126/science.abd2638 |
0.379 |
|
2020 |
Li X, Giorgi EE, Marichannegowda MH, Foley B, Xiao C, Kong XP, Chen Y, Gnanakaran S, Korber B, Gao F. Emergence of SARS-CoV-2 through recombination and strong purifying selection. Science Advances. 6. PMID 32937441 DOI: 10.1126/Sciadv.Abb9153 |
0.35 |
|
2020 |
Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, Hengartner N, Giorgi EE, Bhattacharya T, Foley B, Hastie KM, Parker MD, Partridge DG, Evans CM, Freeman TM, et al. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. Cell. PMID 32697968 DOI: 10.1016/J.Cell.2020.06.043 |
0.37 |
|
2020 |
Hompe ED, Mangold JF, Kumar A, Eudailey JA, McGuire E, Haynes BF, Moody MA, Wright PF, Fouda GG, Giorgi EE, Gao F, Permar SR. Induction of Neutralizing Responses against Autologous Virus in Maternal HIV Vaccine Trials. Msphere. 5. PMID 32493720 DOI: 10.1128/mSphere.00254-20 |
0.47 |
|
2020 |
Giorgi EE, Li H, Bhattacharya T, Shaw GM, Korber B. Estimating the Timing of Early Simian-Human Immunodeficiency Virus Infections: a Comparison between Poisson Fitter and BEAST. Mbio. 11. PMID 32209678 DOI: 10.1128/Mbio.00324-20 |
0.522 |
|
2020 |
Martinez DR, Tu JJ, Kumar A, Mangold JF, Mangan RJ, Goswami R, Giorgi EE, Chen J, Mengual M, Douglas AO, Heimsath H, Saunders KO, Nicely NI, Eudailey J, Hernandez G, et al. Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants. Mbio. 11. PMID 32156815 DOI: 10.1128/Mbio.00176-20 |
0.49 |
|
2019 |
Bricault CA, Yusim K, Seaman MS, Yoon H, Theiler J, Giorgi EE, Wagh K, Theiler M, Hraber P, Macke JP, Kreider EF, Learn GH, Hahn BH, Scheid JF, Kovacs JM, et al. HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design. Cell Host & Microbe. 26: 296. PMID 31415756 DOI: 10.1016/j.chom.2019.07.016 |
0.335 |
|
2019 |
Bricault CA, Yusim K, Seaman MS, Yoon H, Theiler J, Giorgi EE, Wagh K, Theiler M, Hraber P, Macke JP, Kreider EF, Learn GH, Hahn BH, Scheid JF, Kovacs JM, et al. HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design. Cell Host & Microbe. 25: 59-72.e8. PMID 30629920 DOI: 10.1016/J.Chom.2018.12.001 |
0.466 |
|
2018 |
Wagh K, Kreider EF, Li Y, Barbian HJ, Learn GH, Giorgi E, Hraber PT, Decker TG, Smith AG, Gondim MV, Gillis L, Wandzilak J, Chuang GY, Rawi R, Cai F, et al. Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth. Cell Reports. 25: 893-908.e7. PMID 30355496 DOI: 10.1016/J.Celrep.2018.09.087 |
0.511 |
|
2018 |
Saphire EO, Schendel SL, Fusco ML, Gangavarapu K, Gunn BM, Wec AZ, Halfmann PJ, Brannan JM, Herbert AS, Qiu X, Wagh K, He S, Giorgi EE, Theiler J, Pommert KBJ, et al. Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection. Cell. 174: 938-952.e13. PMID 30096313 DOI: 10.1016/J.Cell.2018.07.033 |
0.376 |
|
2018 |
Ke R, Li H, Wang S, Ding W, Ribeiro RM, Giorgi EE, Bhattacharya T, Barnard RJO, Hahn BH, Shaw GM, Perelson AS. Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence. Proceedings of the National Academy of Sciences of the United States of America. PMID 29987026 DOI: 10.1073/Pnas.1805267115 |
0.424 |
|
2018 |
Song H, Giorgi EE, Ganusov VV, Cai F, Athreya G, Yoon H, Carja O, Hora B, Hraber P, Romero-Severson E, Jiang C, Li X, Wang S, Li H, Salazar-Gonzalez JF, et al. Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection. Nature Communications. 9: 1928. PMID 29765018 DOI: 10.1038/S41467-018-04217-5 |
0.556 |
|
2018 |
Kumar A, Smith CEP, Giorgi EE, Eudailey J, Martinez DR, Yusim K, Douglas AO, Stamper L, McGuire E, LaBranche CC, Montefiori DC, Fouda GG, Gao F, Permar SR. Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma. Plos Pathogens. 14: e1006944. PMID 29672607 DOI: 10.1371/Journal.Ppat.1006944 |
0.419 |
|
2017 |
Gao N, Wang W, Wang C, Gu T, Guo R, Yu B, Kong W, Qin C, Giorgi EE, Chen Z, Townsley S, Hu SL, Yu X, Gao F. Development of broad neutralization activity in SHIV-infected rhesus macaques after long-term infection. Aids (London, England). PMID 29239895 DOI: 10.1097/Qad.0000000000001724 |
0.489 |
|
2017 |
Rademeyer C, Korber B, Seaman MS, Giorgi EE, Thebus R, Robles A, Sheward DJ, Wagh K, Garrity J, Carey BR, Gao H, Greene KM, Tang H, Bandawe GP, Marais JC, et al. Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization. Plos Pathogens. 13: e1006641. PMID 28945784 DOI: 10.1371/journal.ppat.1006641 |
0.333 |
|
2016 |
Song H, Hora B, Giorgi EE, Kumar A, Cai F, Bhattacharya T, Perelson AS, Gao F. Transmission of Multiple HIV-1 Subtype C Transmitted/founder Viruses into the Same Recipients Was not Determined by Modest Phenotypic Differences. Scientific Reports. 6: 38130. PMID 27909304 DOI: 10.1038/Srep38130 |
0.47 |
|
2016 |
Rademeyer C, Korber B, Seaman MS, Giorgi EE, Thebus R, Robles A, Sheward DJ, Wagh K, Garrity J, Carey BR, Gao H, Greene KM, Tang H, Bandawe GP, Marais JC, et al. Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization. Plos Pathogens. 12: e1005742. PMID 27434311 DOI: 10.1371/Journal.Ppat.1005742 |
0.535 |
|
2015 |
Love TM, Park SY, Giorgi EE, Mack WJ, Perelson AS, Lee HY. SPMM: estimating infection duration of multi-variant HIV-1 infections. Bioinformatics (Oxford, England). PMID 26722117 DOI: 10.1093/Bioinformatics/Btv749 |
0.552 |
|
2015 |
Hraber P, Korber B, Wagh K, Giorgi EE, Bhattacharya T, Gnanakaran S, Lapedes AS, Learn GH, Kreider EF, Li Y, Shaw GM, Hahn BH, Montefiori DC, Alam SM, Bonsignori M, et al. Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants. Viruses. 7: 5443-75. PMID 26506369 DOI: 10.3390/V7102881 |
0.387 |
|
2015 |
Li H, Stoddard M, Wang S, Giorgi EE, Blair L, Learn G, Hahn B, Alter H, Busch M, Fierer D, Ribeiro RM, Perelson AS, Bhattacharya T, Shaw GM. Single Genome Sequencing of Hepatitis C Virus in Donor-Recipient Pairs Distinguishes Modes and Models of Virus Transmission and Early Diversification. Journal of Virology. PMID 26468546 DOI: 10.1128/Jvi.02156-15 |
0.436 |
|
2015 |
Santra S, Tomaras GD, Warrier R, Nicely NI, Liao HX, Pollara J, Liu P, Alam SM, Zhang R, Cocklin SL, Shen X, Duffy R, Xia SM, Schutte RJ, Pemble Iv CW, ... ... Giorgi EE, et al. Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques. Plos Pathogens. 11: e1005042. PMID 26237403 DOI: 10.1371/Journal.Ppat.1005042 |
0.553 |
|
2015 |
Hulot SL, Korber B, Giorgi EE, Vandergrift N, Saunders KO, Balachandran H, Mach LV, Lifton MA, Pantaleo G, Tartaglia J, Phogat S, Jacobs B, Kibler K, Perdiguero B, Gomez CE, et al. Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost. Journal of Virology. 89: 6462-80. PMID 25855741 DOI: 10.1128/Jvi.00383-15 |
0.488 |
|
2015 |
Bricault CA, Kovacs JM, Nkolola JP, Yusim K, Giorgi EE, Shields JL, Perry J, Lavine CL, Cheung A, Ellingson-Strouss K, Rademeyer C, Gray GE, Williamson C, Stamatatos L, Seaman MS, et al. A multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual component. Journal of Virology. 89: 2507-19. PMID 25540368 DOI: 10.1128/Jvi.03331-14 |
0.478 |
|
2014 |
Hraber P, Korber BT, Lapedes AS, Bailer RT, Seaman MS, Gao H, Greene KM, McCutchan F, Williamson C, Kim JH, Tovanabutra S, Hahn BH, Swanstrom R, Thomson MM, Gao F, ... ... Giorgi E, et al. Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies. Journal of Virology. 88: 12623-43. PMID 25142591 DOI: 10.1128/Jvi.01705-14 |
0.544 |
|
2014 |
Nkolola JP, Bricault CA, Cheung A, Shields J, Perry J, Kovacs JM, Giorgi E, van Winsen M, Apetri A, Brinkman-van der Linden EC, Chen B, Korber B, Seaman MS, Barouch DH. Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimer. Journal of Virology. 88: 9538-52. PMID 24965452 DOI: 10.1128/Jvi.01739-14 |
0.51 |
|
2014 |
Giorgi EE, Balachandran H, Muldoon M, Letvin NL, Haynes BF, Korber BT, Santra S. Cross-reactive potential of human T-lymphocyte responses in HIV-1 infection. Vaccine. 32: 3995-4000. PMID 24837783 DOI: 10.1016/J.Vaccine.2014.04.040 |
0.552 |
|
2013 |
Barouch DH, Stephenson KE, Borducchi EN, Smith K, Stanley K, McNally AG, Liu J, Abbink P, Maxfield LF, Seaman MS, Dugast AS, Alter G, Ferguson M, Li W, Earl PL, ... ... Giorgi EE, et al. Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys. Cell. 155: 531-9. PMID 24243013 DOI: 10.1016/J.Cell.2013.09.061 |
0.517 |
|
2013 |
Giorgi EE, Korber BT, Perelson AS, Bhattacharya T. Modeling sequence evolution in HIV-1 infection with recombination. Journal of Theoretical Biology. 329: 82-93. PMID 23567647 DOI: 10.1016/J.Jtbi.2013.03.026 |
0.489 |
|
2013 |
Parrish NF, Gao F, Li H, Giorgi EE, Barbian HJ, Parrish EH, Zajic L, Iyer SS, Decker JM, Kumar A, Hora B, Berg A, Cai F, Hopper J, Denny TN, et al. Phenotypic properties of transmitted founder HIV-1. Proceedings of the National Academy of Sciences of the United States of America. 110: 6626-33. PMID 23542380 DOI: 10.1073/Pnas.1304288110 |
0.513 |
|
2013 |
Yusim K, Dilan R, Borducchi E, Stanley K, Giorgi E, Fischer W, Theiler J, Marcotrigiano J, Korber B, Barouch DH. Hepatitis C genotype 1 mosaic vaccines are immunogenic in mice and induce stronger T-cell responses than natural strains. Clinical and Vaccine Immunology : Cvi. 20: 302-5. PMID 23221002 DOI: 10.1128/Cvi.00605-12 |
0.318 |
|
2012 |
Li H, Stoddard MB, Wang S, Blair LM, Giorgi EE, Parrish EH, Learn GH, Hraber P, Goepfert PA, Saag MS, Denny TN, Haynes BF, Hahn BH, Ribeiro RM, Perelson AS, et al. Elucidation of hepatitis C virus transmission and early diversification by single genome sequencing. Plos Pathogens. 8: e1002880. PMID 22927816 DOI: 10.1371/Journal.Ppat.1002880 |
0.461 |
|
2012 |
Lee HY, Giorgi EE, Keele BF, Gaschen B, Athreya GS, Salazar-Gonzalez JF, Pham KT, Goepfert PA, Kilby JM, Saag MS, Delwart EL, Busch MP, Hahn BH, Shaw GM, Korber BT, et al. Corrigendum to "Modeling sequence evolution in acute HIV-1 infection" [J. Theor. Biol. 261 (2009) 341-360] Journal of Theoretical Biology. 297: 187. DOI: 10.1016/J.Jtbi.2011.12.010 |
0.507 |
|
2011 |
Boeras DI, Hraber PT, Hurlston M, Evans-Strickfaden T, Bhattacharya T, Giorgi EE, Mulenga J, Karita E, Korber BT, Allen S, Hart CE, Derdeyn CA, Hunter E. Role of donor genital tract HIV-1 diversity in the transmission bottleneck. Proceedings of the National Academy of Sciences of the United States of America. 108: E1156-63. PMID 22065783 DOI: 10.1073/Pnas.1103764108 |
0.521 |
|
2011 |
Whitney JB, Hraber PT, Luedemann C, Giorgi EE, Daniels MG, Bhattacharya T, Rao SS, Mascola JR, Nabel GJ, Korber BT, Letvin NL. Genital tract sequestration of SIV following acute infection. Plos Pathogens. 7: e1001293. PMID 21379569 DOI: 10.1371/Journal.Ppat.1001293 |
0.453 |
|
2011 |
Cale EM, Hraber P, Giorgi EE, Fischer W, Bhattacharya T, Leitner T, Yeh WW, Gleasner C, Green LD, Han CS, Korber B, Letvin NL. Epitope-specific CD8+ T lymphocytes cross-recognize mutant simian immunodeficiency virus (SIV) sequences but fail to contain very early evolution and eventual fixation of epitope escape mutations during SIV infection. Journal of Virology. 85: 3746-57. PMID 21307185 DOI: 10.1128/Jvi.02420-10 |
0.45 |
|
2010 |
Giorgi EE, Funkhouser B, Athreya G, Perelson AS, Korber BT, Bhattacharya T. Estimating time since infection in early homogeneous HIV-1 samples using a poisson model. Bmc Bioinformatics. 11: 532. PMID 20973976 DOI: 10.1186/1471-2105-11-532 |
0.482 |
|
2010 |
Fischer W, Ganusov VV, Giorgi EE, Hraber PT, Keele BF, Leitner T, Han CS, Gleasner CD, Green L, Lo CC, Nag A, Wallstrom TC, Wang S, McMichael AJ, Haynes BF, et al. Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. Plos One. 5: e12303. PMID 20808830 DOI: 10.1371/Journal.Pone.0012303 |
0.529 |
|
2010 |
Li H, Bar KJ, Wang S, Decker JM, Chen Y, Sun C, Salazar-Gonzalez JF, Salazar MG, Learn GH, Morgan CJ, Schumacher JE, Hraber P, Giorgi EE, Bhattacharya T, Korber BT, et al. High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. Plos Pathogens. 6: e1000890. PMID 20485520 DOI: 10.1371/Journal.Ppat.1000890 |
0.577 |
|
2010 |
Goonetilleke N, Liu M, Ganusov V, Giorgi E, Salazar J, Li H, Kirchner J, Turnbull E, Bourne V, Moore S, Yang H, Keele B, Borrow P, Cohen M, Perelson A, et al. The Role of T Cell Immunity in the Control of HIV Infection International Journal of Infectious Diseases. 14: e19-e20. DOI: 10.1016/J.Ijid.2010.02.1528 |
0.487 |
|
2009 |
Lee HY, Giorgi EE, Keele BF, Gaschen B, Athreya GS, Salazar-Gonzalez JF, Pham KT, Goepfert PA, Kilby JM, Saag MS, Delwart EL, Busch MP, Hahn BH, Shaw GM, Korber BT, et al. Modeling sequence evolution in acute HIV-1 infection. Journal of Theoretical Biology. 261: 341-60. PMID 19660475 DOI: 10.1016/J.Jtbi.2009.07.038 |
0.546 |
|
2009 |
Bimber BN, Chugh P, Giorgi EE, Kim B, Almudevar AL, Dewhurst S, O'Connor DH, Lee HY. Nef gene evolution from a single transmitted strain in acute SIV infection. Retrovirology. 6: 57. PMID 19505314 DOI: 10.1186/1742-4690-6-57 |
0.549 |
|
2009 |
Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, Li H, Decker JM, Wang S, Baalwa J, Kraus MH, Parrish NF, Shaw KS, Guffey MB, Bar KJ, Davis KL, et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. The Journal of Experimental Medicine. 206: 1273-89. PMID 19487424 DOI: 10.1084/Jem.20090378 |
0.58 |
|
2009 |
Goonetilleke N, Liu MK, Salazar-Gonzalez JF, Ferrari G, Giorgi E, Ganusov VV, Keele BF, Learn GH, Turnbull EL, Salazar MG, Weinhold KJ, Moore S, Letvin N, Haynes BF, et al. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. The Journal of Experimental Medicine. 206: 1253-72. PMID 19487423 DOI: 10.1084/Jem.20090365 |
0.527 |
|
2009 |
Wood N, Bhattacharya T, Keele BF, Giorgi E, Liu M, Gaschen B, Daniels M, Ferrari G, Haynes BF, McMichael A, Shaw GM, Hahn BH, Korber B, Seoighe C. HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC. Plos Pathogens. 5: e1000414. PMID 19424423 DOI: 10.1371/Journal.Ppat.1000414 |
0.55 |
|
2009 |
Keele BF, Li H, Learn GH, Hraber P, Giorgi EE, Grayson T, Sun C, Chen Y, Yeh WW, Letvin NL, Mascola JR, Nabel GJ, Haynes BF, Bhattacharya T, Perelson AS, et al. Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. The Journal of Experimental Medicine. 206: 1117-34. PMID 19414559 DOI: 10.1084/Jem.20082831 |
0.581 |
|
2009 |
Abrahams MR, Anderson JA, Giorgi EE, Seoighe C, Mlisana K, Ping LH, Athreya GS, Treurnicht FK, Keele BF, Wood N, Salazar-Gonzalez JF, Bhattacharya T, Chu H, Hoffman I, Galvin S, et al. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. Journal of Virology. 83: 3556-67. PMID 19193811 DOI: 10.1128/Jvi.02132-08 |
0.492 |
|
2009 |
Fischer W, Keele B, Bhattacharya T, Lo C, Giorgi E, Hraber P, Leitner T, Han C, Gleasner C, Green L, Hahn B, Shaw G, Haynes B, Korber B. P09-21 LB. Deep sequencing of HIV-1 from acute infection: Low initial diversity, and rapid but variable CTL escape Retrovirology. 6: P401. DOI: 10.1186/1742-4690-6-S3-P401 |
0.369 |
|
2009 |
Liu M, Ferrari G, Salazar J, Keele B, Tanner R, Hraber P, Giorgi E, Ganusov V, Learn G, Salazar M, Moore S, Digleria K, Yu Z, Rostron T, DeBoer C, et al. OA06-04. The role of early T-cell responses in subjects with acute HIV-1 infection Retrovirology. 6. DOI: 10.1186/1742-4690-6-S3-O40 |
0.477 |
|
2009 |
Abrahams MR, Anderson JA, Giorgi EE, Seoighe C, Mlisana K, Ping LH, Athreya GS, Treurnicht FK, Keele BF, Wood N, Salazar-Gonzalez JF, Bhattacharya T, Chu H, Hoffman I, Galvin S, et al. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants (Journal of Virology (2009) 83, 8, (3556-3567)) Journal of Virology. 83: 6974. DOI: 10.1128/Jvi.00832-09 |
0.441 |
|
2008 |
Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, Sun C, Grayson T, Wang S, Li H, Wei X, Jiang C, Kirchherr JL, Gao F, Anderson JA, et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proceedings of the National Academy of Sciences of the United States of America. 105: 7552-7. PMID 18490657 DOI: 10.1073/Pnas.0802203105 |
0.611 |
|
Show low-probability matches. |